PTMEY yields 171.23% · PFE yields 6.13%● Live data
📍 PTMEY pulled ahead of the other in Year 1
Combined, PTMEY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PTMEY + PFE for your $10,000?
PT. Media Nusantara Citra Tbk operates as a media company in Indonesia. It operates through Television, Radio, Print Media, Content, and Advertising Agency segments. The company owns and operates national free-to-air televisions (TV), such as RCTI TV station that offers a range of programs, including drama series, box office movies, sports events, talent search shows, reality and music shows, anniversary and awards programs, and infotainment programs; MNCTV, which offers family drama series, animation, sports programs, and various shows; GTV that focuses on animation, variety shows, reality shows, game shows, and talent search programs; and iNews TV, which focuses on sports and other factual programs, as well as offers content library and talent management services. It also operates StarPro, which provides an infotainment channel on pay-TV platforms; Okezone.com, IDXChannel.com, and Sindonews.com news portals that serve Indonesian readers; RCTI+, an entertainment app; iNews.id, a news portal comprising national and regional news; Celebrities.id, a portal around celebrities and lifestyle; sportstars.id; StarHits, a digital creator network; ROOV, a radio streaming website; and eTV Mall, which allows TV viewers to purchase e-vouchers from advertisements on a TV program. The company was founded in 1987 and is headquartered in Jakarta Pusat, Indonesia. PT. Media Nusantara Citra Tbk is a subsidiary of PT Global Mediacom Tbk.
Full PTMEY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.